Nucleic Acid Extraction Kit Industry Trends and Compliance-Based Purchasing Recommendations

I. Industry Development Trends

In recent years, growing demand for molecular testing has driven nucleic acid extraction kits toward automation, high throughput, and compatibility with multiple sample types. Due to their suitability for automated operation, magnetic bead-based methods are increasingly common in clinical and testing institutions. Pre-dispensed reagents, sealed cartridges, and integrated sample processing solutions help reduce manual errors and contamination risks while improving standardization. Some products support simultaneous extraction of DNA and RNA from the same sample, or offer specialized protocols for special samples such as plasma cell-free DNA, paraffin-embedded tissue, and stool, meeting the needs of different downstream testing platforms.

Domestic nucleic acid extraction kits have continued to improve in performance stability, batch consistency, and supply chain responsiveness, and more laboratories are beginning to conduct comprehensive evaluations based on budget, sample volume, and platform compatibility. At the same time, the degree of compatibility between automated extraction instruments and kits also affects overall efficiency, and differences between open platforms and closed platforms should be considered during procurement.

II. Compliance and Registration Requirements

In mainland China, nucleic acid extraction kits used for in vitro diagnostics shall be filed or registered in accordance with regulations related to medical devices or in vitro diagnostic reagents. When purchasing, users may require suppliers to provide corresponding filing certificates or registration certificate information, and verify the scope of application, sample types, and storage conditions. Kits used for research are generally only suitable for non-clinical research and should not be directly used for clinical diagnosis. If the product is related to pathogen detection, attention should also be paid to whether its intended use, applicable samples, and detection system match the laboratory's own workflow.

Quality management systems are also an important dimension for evaluating suppliers. Materials such as the manufacturer's production license, quality management system certification, and batch inspection reports help assess the continuity and traceability of product supply. Imported products also require consideration of cold-chain transportation, customs clearance, and supply cycles. Laboratories should retain kit instructions, batch numbers, and acceptance records to enable retrospective investigation when performance fluctuations occur.

III. Enterprise Procurement and Supply Chain Management

When purchasing nucleic acid extraction kits, it is recommended to first clarify the performance requirements of the testing project, such as trace samples, low-concentration targets, automated throughput, and purification time, and then conduct small-batch performance verification. Several representative positive and negative samples may be selected to compare nucleic acid concentration, purity, integrity after extraction, and downstream amplification results. Verification results should be documented in writing as a basis for qualified supplier evaluation.

Regarding supply chain stability, consider the supplier's production capacity, inventory, and logistics timeliness, especially the ability to supply during seasonal testing peaks or public health emergencies. Establish safety stock for critical reagents and confirm alternative plans or emergency supply mechanisms with suppliers. Price should not be the sole decision-making factor; quality, compliance, technical support, and after-sales response should be comprehensively evaluated. Regularly re-evaluating supplier performance helps ensure the continuity of testing work and the reliability of results.